S
Sarcoma: adjuvant chemotherapy, systematic review and IPD meta-analysis
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual participant data
SELPHI
SELPHI: An HIV Self-testing Public Health Intervention
SHIELD
A phase II double-blind, placebo controlled, randomised, single centre study to assess the safety, tolerability and acceptability of dextrin-2-sulphate (DS) gel in sexually active female subjects and their male sexual partners at low risk of HIV infection
SHINE
A randomised trial of therapy shortening for minimal tuberculosis with new WHO-recommended doses/fixed-dose-combination drugs in African and Indian HIV+ and HIV- children
SimpliciTB
Evaluating the efficacy, safety and tolerability of a novel and potentially shorter drug regimen (BPaMZ) for patients with drug-sensitive (DS) and drug-resistant (MDR-) pulmonary tuberculosis
SMAART
Severe Malaria - A Research and Trials consortium
SMART
A large, simple trial comparing two strategies for management of anti-retroviral therapy
SMILE
Strategy for Maintenance of HIV suppression with once daily integrase inhibitor +darunavir/ritonavir in children
SNAP
Which standard of care antibiotic intervention is the most effective?
SORCE
A multi-centre phase III double-blind placebo-controlled study designed to examine the efficacy and tolerability of sorafenib (Nexavar) in patients with resected (total or partial) primary renal cell carcinoma (RCC) at high or intermediate risk of relapse
SPARTAC
Short Pulse Anti-Retroviral Therapy At sero-Conversion
ST02
A randomised, controlled trial of pre- and post-operative chemotherapy in patients with operable gastric and lower oesophageal cancer
ST03
A randomised phase II/III trial of perioperative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma and a feasibility study evaluating lapatinib in HER-2 positive oesophagogastric adenocarcinomas and (in selected centres) MRI and PET/CT sub-studies
STAMPEDE
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy
STAND
Shorter Treatment for Advancing Novel Drugs
START
Strategic Timing of AntiRetroviral Treatment
STOP-HCV-1
Stratified Treatment Optimisation for HCV-1
STOPCAP M0, bisphosphonates, systematic review and aggregate data meta-analysis
Addition of bisphosphonates to standard of care in men with localised, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
STOPCAP M0, docetaxel, systematic review and aggregate data meta-analysis
Addition of docetaxel to standard of care in men with localised hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
STOPCAP M1 Programme
Speeding up the evaluation of therapies for metastatic, hormone-sensitive prostate cancer
STOPCAP M1, abiraterone, systematic review and aggregate data meta-analysis
Addition of abiraterone to standard of care in men with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
STOPCAP M1, aggregate data network meta-analysis
What is the optimal systemic treatment of men with metastatic, hormone-sensitive prostate cancer? a systematic review and network meta-analyses of aggregate data
STOPCAP M1, bisphosphonates, systematic review and aggregate data meta-analysis
Addition of bisphosphonates to standard of care in men with metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
STOPCAP M1, docetaxel, systematic review and aggregate data meta-analysis
Addition of docetaxel to standard of care in men with metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
STOPCAP M1, prostate RT, systematic review and aggregate data meta-analysis
Addition of prostate radiotherapy to ADT in men with metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
STREAM Stage 1
The evaluation of a standardised treatment regimen of anti-tuberculosis drugs for patients with MDR-TB
STREAM Stage 2
The Evaluation of a Standardised Treatment Regimen of Anti-Tuberculosis Drugs for Patients with MDR-TB
STRIVE
Strategies and Treatments for Respiratory Infections & Viral Emergencies
Study C
A randomised international multi-centre trial for the evaluation of a four-drug fixed dose combined tablet daily in the initial phase (2 months) of chemotherapy followed by a two-drug fixed dose combined tablet three times a week in the continuation phase (4 months) for the treatment of pulmonary tuberculosis.
SURE
A randomised trial of 6 months intensified anti-tuberculosis and 2 months anti-inflammatory treatment for HIV-infected and HIV-uninfected African and Asian children with tuberculous meningitis
SWET
Softened Water Eczema Trial
STAMPEDE2
Studying Treatments in patients receiving androgen deprivation therapy (ADT) and androgen receptor signalling inhibitors (ARSI) for Metastatic Prostate Cancer: Evaluation of Drug and radiation Efficacy: A 2nd multi-arm multi-stage randomised controlled trial (STAMPEDE2).
SNIP-AFRICA
Severe neonatal infection adaptive platform trials in Africa